Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

TET2mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow

(2013) Khaled Alayed et al.   AMERICAN JOURNAL OF HEMATOLOGY

Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation

(2013) Mohamed A. Kharfan-Dabaja et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia

(2013) A. Mardiros et al.   BLOOD

Monoclonal antibody targeting of IL-3 receptor   with CSL362 effectively depletes CML progenitor and stem cells

(2013) E. Nievergall et al.   BLOOD

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients

(2013) F. Julia et al.   BRITISH JOURNAL OF DERMATOLOGY

Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor

(2013) Sarah Tettamanti et al.   BRITISH JOURNAL OF HAEMATOLOGY

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study

(2013) L. Pagano et al.   HAEMATOLOGICA

Macrophages and Recently Identified Forms of Cell Death

(2013) Ana B. Sanz et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Characterization of CD56+ Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?

(2013) Yohei Osaki et al.   PLoS One

Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus

(2013) R. Baccala et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

(2012) D. Roos-Weil et al.   BLOOD

Pilot Study of Denileukin Diftitox Alternate Dosing Regimen in Patients With Cutaneous Peripheral T-Cell Lymphomas

(2012) Rakhshandra Talpur et al.   Clinical Lymphoma Myeloma & Leukemia

Auger Electron Radioimmunotherapeutic Agent Specific for the CD123+/CD131- Phenotype of the Leukemia Stem Cell Population

(2011) J. V. Leyton et al.   JOURNAL OF NUCLEAR MEDICINE

Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells

(2010) Christoph Stein et al.   BRITISH JOURNAL OF HAEMATOLOGY

A diphtheria toxin interleukin-3 fusion protein synergizes with tyrosine kinase inhibitors in killing leukemic progenitors from BCR/ABL positive acute leukemia

(2010) Hyun Pyo Kim et al.   LEUKEMIA RESEARCH

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia

(2009) Francine Garnache-Ottou et al.   BRITISH JOURNAL OF HAEMATOLOGY

Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure

(2009) Te-Wei Chen et al.   EXPERIMENTAL HEMATOLOGY

New response criteria for lymphomas in clinical trials

(2008) B. D. Cheson   ANNALS OF ONCOLOGY

Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia

(2008) Arthur Frankel et al.   LEUKEMIA & LYMPHOMA